{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:00:16Z","timestamp":1777550416236,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.micpath.2020.104198","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T02:05:19Z","timestamp":1586484319000},"page":"104198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection"],"prefix":"10.1016","volume":"144","author":[{"given":"Masoud","family":"Keikha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiarash","family":"Ghazvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-2885","authenticated-orcid":false,"given":"Mohsen","family":"Karbalaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.micpath.2020.104198_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/v10120691","article-title":"Cytokine networks dysregulation during HTLV-1 infection and associated diseases","volume":"10","author":"Futsch","year":"2018","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib2","first-page":"60","article-title":"The relevance of HTLV-1-associated myelopathy\/tropical spastic paraparesis in Iran: a review study","volume":"6","author":"Keikha","year":"2019","journal-title":"Rev. Clin. Med."},{"issue":"12","key":"10.1016\/j.micpath.2020.104198_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/bloodadvances.2016001370","article-title":"Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-\u03b1","volume":"1","author":"Macchi","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.micpath.2020.104198_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biopha.2018.10.139","article-title":"Molecular targeting for treatment of human T-lymphotropic virus type 1 infection","volume":"109","author":"Soltani","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6\u20137","key":"10.1016\/j.micpath.2020.104198_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","article-title":"Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity","volume":"20","author":"Starling","year":"2015","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib6","article-title":"The indinavir derivate as a novel pharmacophore for treatment of HTLV-1 viral infections","volume":"13","author":"Brites","year":"2019","journal-title":"Iran. J. Virol."},{"key":"10.1016\/j.micpath.2020.104198_bib7","series-title":"The Design of Novel Kni-10729 Based Compound for Inhibition of HTLV-1 Protease as Novel Insight for Development of Anti-HTLV Drugs","author":"Keikha","year":"2019"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib8","doi-asserted-by":"crossref","DOI":"10.5812\/jjhr.92813","article-title":"Curcumin as an herbal inhibitor candidate against HTLV-1 protease","volume":"10","author":"Karbalaei","year":"2019","journal-title":"Jentashapir J. Health Res."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.micpath.2020.104198_bib10","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2020.104198_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2014.03.025","article-title":"Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"104","author":"Fuzii","year":"2014","journal-title":"Life Sci."},{"issue":"39","key":"10.1016\/j.micpath.2020.104198_bib12","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1038\/sj.onc.1208976","article-title":"Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response","volume":"24","author":"Marriott","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib13","article-title":"The miR-29 family as novel therapeutic option for retroviral infection; Letter to the editor","volume":"12","author":"Keikha","year":"2018","journal-title":"Iran. J. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-019-0508-8","article-title":"An insight to HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis","volume":"16","author":"Mozhgani","year":"2019","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/v8010005","article-title":"HTLV-1, immune response and autoimmunity","volume":"8","author":"Quaresma","year":"2016","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micpath.2020.104198_bib16","first-page":"179","article-title":"Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia\/lymphoma (ATL)","volume":"16","author":"Ghezeldasht","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.micpath.2020.104198_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","article-title":"Reducing the global burden of HTLV-1 infection: an agenda for research and action","volume":"137","author":"Willems","year":"2017","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib18","first-page":"1","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.micpath.2020.104198_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/jjcdc.93351","article-title":"What is adult T-cell leukemia pathogenesis? system virology as a solution of this puzzle","volume":"8","author":"Karbalaei","year":"2019","journal-title":"Jundishapur J Chronic Dis Care"},{"key":"10.1016\/j.micpath.2020.104198_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/978-3-319-33919-1_42","article-title":"Human T-cell lymphotropic virus type-1 (HTLV-1) infection in dermatology","author":"Bittencourt","year":"2018","journal-title":"Dermatol. Pub. Health Environ : Spring"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/v8020040","article-title":"Mother-to-child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother-to-child transmission","volume":"8","author":"Percher","year":"2016","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/exd.12511","article-title":"DC\u2013T cell virological synapses and the skin: novel perspectives in dermatology","volume":"24","author":"Shimauchi","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"14","key":"10.1016\/j.micpath.2020.104198_bib24","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1128\/JVI.00007-11","article-title":"Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-\u03baB-dependent induction of SOCS1","volume":"85","author":"Charoenthongtrakul","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2020.104198_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.micpath.2020.104198_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001177","article-title":"HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)","volume":"6","author":"Oliere","year":"2010","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib27","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jdermsci.2017.02.202","article-title":"Cell-to-cell contact with HTLV-1-infected T cell reduces dendritic cell immune functions and contributes to infection in trans","volume":"86","author":"Shimauchi","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"18","key":"10.1016\/j.micpath.2020.104198_bib28","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1128\/JVI.00887-07","volume":"81","author":"Banerjee","year":"2007","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.micpath.2020.104198_bib29","article-title":"KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection","volume":"7","author":"Al Basatena","year":"2011","journal-title":"PLoS Pathog."},{"issue":"33","key":"10.1016\/j.micpath.2020.104198_bib30","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.vaccine.2018.07.002","article-title":"In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection","volume":"36","author":"Mulherkar","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micpath.2020.104198_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v8030074","article-title":"Molecular mechanisms of HTLV-1 cell-to-cell transmission","volume":"8","author":"Gross","year":"2016","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.micpath.2020.104198_bib32","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.0900069","article-title":"The avidity and lytic efficiency of the CTL response to HTLV-1","volume":"182","author":"Kattan","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104198_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005560","article-title":"CADM1\/TSLC1 identifies HTLV-1-infected cells and determines their susceptibility to CTL-mediated lysis","volume":"12","author":"Manivannan","year":"2016","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.micpath.2020.104198_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"MacNamara","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-8-19","article-title":"ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells","volume":"8","author":"Hagiya","year":"2011","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.micpath.2020.104198_bib36","first-page":"1865","article-title":"HTLV-1 bZIP factor enhances TGF-\u03b2 signaling through p300 coactivator. Blood","volume":"118","author":"Zhao","year":"2011","journal-title":"J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.micpath.2020.104198_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2012.09.028","article-title":"HTLV-1: persistence and pathogenesis","volume":"435","author":"Cook","year":"2013","journal-title":"Virology"},{"issue":"5220","key":"10.1016\/j.micpath.2020.104198_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.micpath.2020.104198_bib40","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1038\/sj.onc.1208507","article-title":"IL-2-and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1","volume":"24","author":"Fung","year":"2005","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.micpath.2020.104198_bib41","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.micpath.2020.104198_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tim.2007.02.006","article-title":"IL-10, T cell exhaustion and viral persistence","volume":"15","author":"Blackburn","year":"2007","journal-title":"Trends Microbiol."},{"issue":"8","key":"10.1016\/j.micpath.2020.104198_bib43","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 induces a Th1-like state in CD4+ CCR4+ T cells","volume":"124","author":"Araya","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib44","first-page":"182","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy","volume":"47","author":"Nakamura","year":"2009","journal-title":"Folia Neuropathol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"18","key":"10.1016\/j.micpath.2020.104198_bib47","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2020.104198_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2017.01.007","article-title":"A review on the evolution of PD-1\/PD-L1 immunotherapy for bladder cancer: the future is now","volume":"54","author":"Bellmunt","year":"2017","journal-title":"Canc. Treat Rev."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molimm.2015.02.009","article-title":"Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy","volume":"67","author":"Swaika","year":"2015","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2020.104198_bib50","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2015.11","article-title":"Targeting PD1\u2013PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells","volume":"29","author":"Ray","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7\u2013CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.micpath.2020.104198_bib53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopha.2018.11.105","article-title":"PD-1\/PD-L1 blockade as a novel treatment for colorectal cancer","volume":"110","author":"Yaghoubi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.micpath.2020.104198_bib54","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD\u20101, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.micpath.2020.104198_bib55","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"issue":"230","key":"10.1016\/j.micpath.2020.104198_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.micpath.2020.104198_bib57","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1194\/jlr.P031260","article-title":"Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells","volume":"54","author":"Jaudszus","year":"2013","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.micpath.2020.104198_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006353","article-title":"Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells","volume":"13","author":"Rizkallah","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2020.104198_bib59","first-page":"268","article-title":"Human T-lymphotropic virus type I (HTLV-I) proviral load and clinical features in Iranian HAM\/TSP patients: comparison of HTLV-I proviral load in HAM\/TSP patients","volume":"16","author":"Vakili","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"9","key":"10.1016\/j.micpath.2020.104198_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PLoS Pathog."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2020.104198_bib61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jneuroim.2007.05.015","article-title":"High production of RANTES and MIP-1\u03b1 in the tropical spastic paraparesis\/HTLV-1-associated myelopathy (TSP\/HAM)","volume":"188","author":"Montanheiro","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.micpath.2020.104198_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.11.009","article-title":"The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis","volume":"228","author":"Tarokhian","year":"2017","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.micpath.2020.104198_bib63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-3083.2009.02291.x","article-title":"The elevated interferon gamma production is an important immunological marker in HAM\/TSP pathogenesis","volume":"70","author":"Montanheiro","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104198_bib64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/376529","article-title":"Majority of interferon-\u03b3-producing CD4+ cells in patients infected with human T cell lymphotrophic virus do not express tax protein","volume":"188","author":"Mitre","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2020.104198_bib65","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1182\/blood-2004-01-0266","article-title":"Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma","volume":"104","author":"Mitra-Kaushik","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.172.1.121","article-title":"Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia","volume":"172","author":"Kim","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2020.104198_bib67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","article-title":"Molecular hallmarks of adult T cell leukemia","volume":"3","author":"Yamagishi","year":"2012","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104198_bib68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.leu.2403628","article-title":"Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells","volume":"19","author":"Matsubara","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+ CD4+ T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.micpath.2020.104198_bib70","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3389\/fimmu.2018.02755","article-title":"The roles of coinhibitory receptors in pathogenesis of human retroviral infections","volume":"9","author":"Yasuma-Mitobe","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2020.104198_bib71","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","article-title":"PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention","volume":"182","author":"Kaufmann","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2020.104198_bib72","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1\u2013PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.micpath.2020.104198_bib73","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/cid\/ciz369","article-title":"Enhanced T-cell maturation and monocyte aggregation are features of cellular inflammation in human T-lymphotropic virus type 1\u2013associated myelopathy","volume":"70","author":"Saeed","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104198_bib74","series-title":"Functional Capacity of Natural Killer Cells in HTLV-1 Associated Myelopathy\/tropical Spastic Paraparesis (HAM\/TSP) Patients","author":"Mascarenhas","year":"2019"},{"issue":"8","key":"10.1016\/j.micpath.2020.104198_bib75","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/cas.13654","article-title":"Human T\u2010cell lymphotropic\/leukemia virus type 1 (HTLV\u20101) Tax\u2010specific T\u2010cell exhaustion in HTLV\u20101\u2010infected individuals","volume":"109","author":"Masaki","year":"2018","journal-title":"Canc. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006120","article-title":"HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors","volume":"13","author":"Kinosada","year":"2017","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.micpath.2020.104198_bib77","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.humimm.2011.07.308","article-title":"Programmed death-1 (PD-1)\/PD-1 ligand pathway\u2013mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders","volume":"72","author":"Kozako","year":"2011","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2020.104198_bib78","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10875-013-9918-x","article-title":"Lack of recall response to Tax in ATL and HAM\/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1","volume":"33","author":"Manuel","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"28","key":"10.1016\/j.micpath.2020.104198_bib79","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.18632\/oncotarget.26763","article-title":"MEF-2 isoforms'(AD) roles in development and tumorigenesis","volume":"10","author":"Madugula","year":"2019","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002028","article-title":"Expansion in CD39+ CD4+ immunoregulatory T cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications","volume":"7","author":"Leal","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virol.2006.07.002","article-title":"Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity","volume":"354","author":"Michael","year":"2006","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.micpath.2020.104198_bib83","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1128\/JVI.02239-09","article-title":"APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo","volume":"84","author":"Fan","year":"2010","journal-title":"J. Virol."},{"issue":"6382","key":"10.1016\/j.micpath.2020.104198_bib84","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.micpath.2020.104198_bib85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.micpath.2020.104198_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12879-019-4032-1","article-title":"Functional capacity of natural killer cells in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients","volume":"19","author":"Queiroz","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib87","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trecan.2016.01.003","article-title":"Anti-CD73 in cancer immunotherapy: awakening new opportunities","volume":"2","author":"Antonioli","year":"2016","journal-title":"Trends Canc."},{"issue":"5","key":"10.1016\/j.micpath.2020.104198_bib88","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1127496","article-title":"CD73-adenosine reduces immune responses and survival in ovarian cancer patients","volume":"5","author":"Gaudreau","year":"2016","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.micpath.2020.104198_bib89","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/annonc\/mdx212","article-title":"Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study","volume":"28","author":"Cabel","year":"2017","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.micpath.2020.104198_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087631","article-title":"HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4\/CD48 interaction in HTLV-1 infection","volume":"9","author":"Ezinne","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.micpath.2020.104198_bib91","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/infdis\/jiq153","article-title":"Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection","volume":"203","author":"Abdelbary","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102030485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102030485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:45:45Z","timestamp":1774928745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102030485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":91,"alternative-id":["S088240102030485X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104198","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104198"}}